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I. INTRODUCTION
Although the origin of the word pharmacy is often attributed to the Greek
pharmakon, meaning remedy,1 the art of combining and compounding agents
existed long before the word came into use.2  Despite the many changes pharmacy
practice has gone through in its long history, the majority of which have occurred
within the last fifty years,3 those in the profession consider it an intensely per-
sonal calling that is guided by basic human values and compassion.4  The role of
the modern-day pharmacist is not that of a mere dispenser of legal medication5—
that categorization undermines the pharmacist’s important role in the clinical
process.6  Rather, pharmacists must achieve a certain expertise to practice their
profession.7  They are independent health care professionals who serve important
roles in their communities by acting as guardians, advisors, and protectors with
respect to the products they dispense.8  This knowledge and sophistication earned
them the 1930 slogan: “Your pharmacist is the scientist on the corner.”9  Recently
however, the federal government has begun to consider a new regulatory scheme
under a bill called the Access to Legal Pharmaceuticals Act (“ALPhA”)10 that
would strictly limit pharmacists’ discretion by limiting their ability to refuse to
fill prescriptions.  This note will argue that the broad language of this bill dispro-
portionately burdens small neighborhood drugstores over corporate chains and
1. DAVID L. COWEN & WILLIAM H. HELFAND, PHARMACY: AN ILLUSTRATED HISTORY 17 (1990).
2. Id .; ROBERT A. BUERKI & LOUIS D. VOTTERO, ETHICAL RESPONSIBILITY IN PHARMACY PRACTICE 1
(2d ed. 2002).
3. See DOUGLAS J. PISANO, ESSENTIALS OF PHARMACY LAW 3–4 (2003) (discussing how the practice of
pharmacy has changed since World War II).
4. BUERKI & VOTTERO, supra note 2, at 1.
5. See  Gregory J. Higby, The Continuing Evolution of American Pharmacy Practice, 1952–2002, in
AMERICAN PHARMACY: A COLLECTION OF HISTORICAL ESSAYS 11, 12–14 (Gregory J. Higby & Elaine
C. Stroud eds. 2005) (discussing the shift from the era of ‘count and pour’ pharmaceutical practice in the
1950s to the birth of clinical pharmacy in the 1960s, which emphasized that the “function of pharmacy is
clinical in nature . . . the sum total of knowledge, understanding, judgments, procedures, skills, controls,
and ethics that assures optimal safety in the distribution and use of medication”).
6. See id.; Freedom of Conscience for Small Pharmacies: Hearing Before the H. Small Bus. Comm.,
109th Cong. 64–66 (2005) (statement of Linda Garrelts MacLean, RPh, CDE, Member American Phar-
macists Ass’n).
7. See  Robert A. Buerki, American Pharmaceutical Education, 1852–1902, in AMERICAN PHARMACY: A
COLLECTION OF HISTORICAL ESSAYS 37–41 (Gregory J. Higby & Elaine C. Stroud eds. 2005) (discuss-
ing the higher standards implemented by pharmacy schools in training pharmacists from 1852–1902);
Robert A. Buerki, American Pharmaceutical Education, 1902–1952, in AMERICAN PHARMACY: A
COLLECTION OF HISTORICAL ESSAYS 43–47 (Gregory J. Higby & Elaine C. Stroud eds. 2005) (same
standards as 1902–1952); Robert A. Buerki, American Pharmaceutical Education, 1952–2002, in
AMERICAN PHARMACY: A COLLECTION OF HISTORICAL ESSAYS 49–52 (Gregory J. Higby & Elaine C.
Stroud eds. 2005) (discussing the increased intensity and standards implemented by pharmacy schools in
training pharmacists from 1952–2002); Statement of Linda Garrelts MacLean, RPh, CDE, supra note
6.
8. BUERKI & VOTTERO, supra note 2, at 2.
9. Id. at 3.
10. H.R. 1652, 109th Cong. (2005).
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compels pharmacists to dispense prescriptions they may have ethical objections to
filling.
Part II of this note briefly explores the history of pharmacy practice and its
development as a regulated profession and business.  Part III of this note explores
the language of the ALPhA, and discusses the problems that the overly broad
language of this statute will create for pharmacy practice.  Finally, Part IV of
this note proposes that the federal government look toward state regulations such
as the guidelines adopted by the New York State Board of Pharmacy, for gui-
dance in tailoring the language of the ALPhA more narrowly.
II. HISTORY AND DEVELOPMENT OF THE MODERN DAY PHARMACIST
At its essence, the practice of pharmacy is the “compounding and dispensing
[of] medications directly to the public . . .”11 and the pharmacist is the health
professional trained to carry out that task.12  However, the practice of pharmacy
is much more than merely disseminating drugs to the masses.13  It is a profession,
requiring years of study and expertise.14  Like many other professions, the prac-
tice of pharmacy is self-regulating, but pharmacists must also follow a regime of
state and federal regulations.15  As the industry becomes more regulated, the issue
of a pharmacist’s discretion to refuse to fill a prescription has become highly
contested.16
A. Emergence of Pharmacy as a Profession
The fundamental roots of pharmaceutical practice can be traced back to an-
cient times.17  As far back as eighty thousand years ago, Paleolithic people began
cultivating and depicting the plant life around them.18 Remains of Neolithic peo-
ple from fifty thousand years ago were discovered with clusters of flowers and
herbs, many of which possessed medicinal properties.19
11. BUERKI & VOTTERO, supra note 2, at 1.
12. Id. at 2.
13. See generally PISANO, supra note 3, at 3–4.
14. See  Buerki, American Pharmaceutical Education, 1852–1902, supra note 7, at 37–41. See generally
RICHARD ABOOD, PHARMACY PRACTICE AND THE LAW 279 (4th ed. 2005); PISANO, supra note 3, at
4–5.
15. See generally ABOOD, supra note 14, at 275–77.
16. See Jody Feder, Federal and State Laws Regarding Pharmacists Who Refuse to Dispense Contra-
ceptives, CRS REPORT FOR CONGRESS 6 (2005); Cynthia Dailard, Beyond the Issue of Pharmacist
Refusals: Pharmacies that Won’t Sell Emergency Contraception, 8 THE GUTTMACHER REPORT ON
PUBLIC POLICY 3 (Guttmacher Inst. 2005).
17. See generally COWEN  & HELFAND, supra note 1, at 17–26.
18. Id. at 17.
19. Id. (“As much as 80,000 years ago, people of the Paleolithic period were sufficiently interested in the flora
around them to engrave a variety of plants and plant parts on bones and deer antlers, and 50,000 years
97
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In early human societies, the medicine man fulfilled the role of the pharma-
cist.20  These men and women served the spiritual, medical, and medicinal needs
of the sick and dying.21  It was their belief that disease could be caused by the
presence of evil spirits, the violation of a taboo, an enemy’s curse, or the departure
of good spirits from the body.22  Once the cause of the disease was determined, the
medicine men would fashion a remedy from various chants, magic objects, and
drinking or smelling potions.23
Artisans of ancient Mesopotamia were among the first recorded to use early
forms of chemistry to produce medicines from natural ingredients.24  Archaeolo-
gists have discovered thousands of clay tablets that recorded the ingredients and
procedures used around 2100 B.C.E. to compound various medicines and reme-
dies.25  This early compounding was a specialized practice, and the medicines
were offered to people in “drug stores” on the streets of ancient Babylonia.26  The
emergence of pharmaceutical practice as a separate and distinct profession
originated in the Middle East in the ninth century, and coincided with the begin-
nings of professional licensure.27  Educated pharmacists were given licenses to
practice in Baghdad near army camps, while uneducated pharmacists were ex-
cluded from this privilege.28
The art of compounding and making medicines further evolved in the Mid-
dle East, India, and China, and eventually spread throughout Europe after the
fall of the Roman Empire.29  Monks preserved ancient medicinal knowledge by
translating early medicinal remedies and compounding techniques into several
languages.30  As chemistry became better understood in the mid-to-late Middle
Ages, European alchemists were more able to develop and prepare medicines.31
ago a Neolithic man was buried in the Shanidar Cave in northern Iraq with clusters of flowers and
herbs.”).
20. Id. at 18 (“In the medicine man’s collection and preparation of remedies lies the beginning of pharmacy.
That a medication might possess powers beyond its effect on bodily function, and that medication was
needed to exorcise evil spirits, were ideas that would affect pharmacy and medicine for ages to come.”).
21. Id. at 17.
22. Id.
23. Id .
24. Id . at 19–20.
25. Id.
26. Id. at 20 (stating that “[a]t least during the Babylonian period there was a special street in Sippur where
retailers of drugs plied their trade”).
27. Id. at 46.
28. Id.; see also GEORGE EDWARD TREASE, PHARMACY IN HISTORY 13–14 (1964).
29. COWEN & HELFAND, supra note 1, at 49–52; see TREASE, supra note 28 (explaining the history of early
alchemy).
30. COWEN & HELFAND, supra note 1, at 49–50.
31. See id. at 50.
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Europe began to define the role of the alchemist and the role of the physician
in 1180 with the emergence of pharmacy ordinances in France.32  In 1240, the
Constitutiones, issued by Holy Roman Emperor Fredrick II, for the first time
legally recognized pharmacy as a distinct profession from that of medicine, and
required pharmacists in all of Western Europe to pledge that they would protect
the public and make uniform quality goods.33  The regulations in the Constitu-
tiones  promoted economic well-being and elevated the social status of trained
and knowledgeable pharmacists.34
In the United States, by contrast, the emergence of pharmacy as a profession,
separate and distinct from that of physicians, evolved more slowly.35  During the
early colonization of America, colonists relied on medical books and kitchen reme-
dies to aid them in compounding medicines and treating illnesses.36  As the new
settlements grew in population and became economically prosperous, apothecary
shops owned and managed by physicians were established in some of the larger
towns.37
The Revolutionary War created, for the first time since the early coloniza-
tion, a generalized need for locally-compounded medicine.38  Because trade to
America was cut off by Britain, physicians, their apprentices, and a new group of
non-medical practitioners were forced to meet patients’ needs by compounding
their own medicines.39  These non-medical practitioners were few in number and
did not belong to any organized profession; they acted independently of each
other.40
It wasn’t until the late eighteenth and early nineteenth centuries that Amer-
ican pharmacists began to be recognized as compounders and dispensers of
medicine, fully distinct from physicians.41  This distinction can be partly attrib-
uted to the organization and popularization of medical schools in the United
States during the early 1800s.42  With more physicians receiving formal training
32. See id. at 52–53.  The ordinances adopted in France recognized pharmacy as a branch of medicine,
regulating the practice of pharmacy under the medicinal police. Id.
33. Id. at 55.  The Constitutiones was a series of edicts regulating the medical profession. Id.
34. Id.
35. See supra notes 32–34 and accompanying text; infra note 42 and accompanying text.
36. Gregory J. Higby, Introduction: American Pharmacy Before 1852, in AMERICAN PHARMACY: A COL-
LECTION OF HISTORICAL ESSAYS ix–x (Gregory J. Higby & Elaine C. Stroud eds. 2005).
37. Id.; see also GLENN SONNEDECKER, KREMERS AND URDANG’S HISTORY OF PHARMACY 152 (4th ed.
1976).
38. Higby, supra note 36, at ix.
39. Id.; see also SONNEDECKER, supra note 37, at 166–68 (explaining the new and growing responsibility of
the American pharmacist).
40. Higby, supra note 36, at x.
41. Id.  See generally SONNEDECKER, supra note 37, at 160–62.
42. Higby, supra note 36, at x.
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in medicine, prescription writing became common practice in the medical profes-
sion.43  Once a prescription was written, the patient would be directed to the
local druggist whom the doctor depended on to correctly compound and dispense
the medicine according to the doctor’s written instructions.44  As physicians’ reli-
ance on druggists’ services increased, physician-authorized books identifying
drugs and detailed instructions on how to make them, called pharmacopoeias,
began to circulate, allowing druggists to prepare a wider and more consistent
range of medicines in line with their clients’ needs.45  Many physicians practicing
between 1820 and 1860 believed that a separation of pharmaceutical and medi-
cal needs was a necessary division of labor.46
In response to the increasing demand of separate pharmaceutical services,
the first pharmacy school opened in Philadelphia in 1822.47  In its early years
there were no requirements for admission into the pharmacy school.48  In order to
graduate, individuals had to pass a written examination, provide proof of four
years of satisfactory apprenticeship with a local druggist, and attend lectures
given by the school two to three evenings a week for several months.49  Even
with these minimal requirements, encouraging druggists to receive formal train-
ing was difficult.50  As of 1860, attendance at pharmacy schools remained
small.51  Out of 11,031 practicing druggists in the nation at that time, only 514
had actually graduated from a pharmacy school.52  These statistics were not a
cause for alarm because it was the general belief that formal instruction merely
rounded off the valuable experience of an extended apprenticeship.53  However,
enrollment increased as states began to mandate formal training of
pharmacists.54
43. Id.
44. Id. Druggists, the title that pharmacists were referred by before the requirement of pharmacy schools,
compounded and sold the drugs to patients. Id.
45. Id.; see also SONNEDECKER, supra note 37, at 260–75 (explaining the history and revision of the U.S.
Pharmacopia).
46. Higby, supra note 36, at x.
47. See PISANO, supra note 3, at 4. See generally, SONNEDECKER, supra note 37, at 190–95 (discussing the
history of the first pharmacy school).
48. Buerki, American Pharmaceutical Education, 1852–1902, supra note 7, at 38.
49. Id.
50. Id. See generally SONNEDECKER, supra note 37, at 227–28 (explaining the financial problems faced by
pharmacy schools by optional education).
51. Buerki, American Pharmaceutical Education, 1852–1902, supra note 7, at 38.
52. Id.
53. Id. at 39. See generally SONNEDECKER, supra note 37, at 237–38 (discussing the importance of intern-
ships in the field).
54. See generally Buerki, American Pharmaceutical Education, 1852–1902, supra note 7, at 39–40 (stat-
ing that pharmacy practice laws that governed education and licensure of pharmacists emerged in the
100
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In the nineteenth and twentieth centuries, in response to the exponential
growth of the pharmaceutical industry, the number of pharmacy schools in-
creased.55  The development of new and complicated drugs at a faster and
cheaper rate enhanced patient care but also increased the chances of injury.56
Consequently, in addition to compounding and preparing certain medicines,
pharmacists also had to hone their skills in therapeutic selection, drug regimen,
drug monitoring, patient counseling, and patient education.57  These develop-
ments created a need to ensure that pharmacy students graduated with high
levels of expertise and professional skills.58
Today, pharmacy schools in the United States require students to complete
six years of study.59  Part of the curriculum includes a hospital residency or a
research fellowship to complement an intense academic training.60  In addition,
the curriculum and accreditation of pharmacy schools are monitored by the Amer-
ican Council on Pharmaceutical Education (“ACPE”).61  An applicant in the pro-
fession must also pass a licensure exam administered by a state board of
pharmacy62 and the Multistate Pharmacy Jurisprudence Exam, which tests
knowledge of relevant state and federal regulations.63  Lastly, applicants must
meet an age requirement, which varies from state to state, and demonstrate good
moral character before receiving a license to practice.64
B. Development of Pharmacy as a Business
Pharmacy is both a profession and a business.65  The earliest pharmacy
shops in history were established in the Middle East between 775 and 785 C.E.,
1880s and coincided with the increase in pharmacy schools). See also SONNEDECKER, supra note 37, at
214–17.
55. PISANO, supra note 3, at 3–4; see also SONNEDECKER, supra note 37, at 333–35 (discussing the increase
in production volume and industry research).
56. PISANO, supra note 3, at 3–4.
57. Id. at 3.
58. Id . at 3–4.
59. Id. at 4.
60. Id . at 4–5.
61. Id . at 5.
62. Id.
63. ABOOD, supra note 14, at 280.
64. Id. at 279.
65. See CHARLES L. HUISKING, HERBS TO HORMONES: THE EVOLUTION OF DRUGS AND CHEMICALS
THAT REVOLUTIONIZED MEDICINE 13 (1968).
The American retail pharmacy has always been an omnibus store.  The colonial druggist
handled spices, herbs, condiments, dyes, tanstuffs and paint materials, all within the general
category of ‘drugs.’  He also sold writing paper, candles and penknives . . . perfumes, rouge
and white powder for wigs; tea, coffee and chocolate; rum, whisky and imported wines.
Such merchandise was the historical forerunner of present-day stocks of paperbacks, greet-
ing cards, records, cameras and photographic supplies.  There has been no revolution in the
101
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where pharmacists privately owned and operated their businesses and performed
a variety of functions as both owners and health professionals.66  Physicians
wrote prescriptions that were filled by both licensed and unlicensed pharma-
cists.67  More importantly, at this time, codes of ethics, standards of cleanliness,
delineation of duties, and standards of practice were developed to further aid the
profession’s business and advancement.68  During the Middle Ages, early phar-
macies in Western Europe reflected these Arab influences in both business and
practice.69  Additionally, pharmacies in Western Europe were characterized by
their small shops that contained shelves of marked bottles, boxes, and leather
bags.70
During the colonization of America in the 1700s, the earliest pharmacies
emerged as apothecary shops.71  These shops sold patented medicines, drugs,
chemicals, spices, and medicines imported from England.72
The early 1800s saw the emergence of what is traditionally thought of as the
classic American drugstore,73 and by 1830 the drugstore was already considered
an American institution.74  The typical American drugstore in the 1850s con-
tained a front end that was considered the pharmacy work area for preparing
medicines.75  The druggist would not only compound and dispense, but also
would supervise a staff of clerks and apprentices who attended to customers and
did much of the hard labor.76  A successful pharmacy practice required both
knowledge of the chemistry of medicines and the business mechanics of owning a
shop.77
variety of goods sold in drugstores, only logical changes to accommodate new items and
serve customers’ new demands.
Id.; see also SONNEDECKER, supra note 37, at 311.
66. COWEN & HELFAND, supra note 1, at 46.
67. See id. at 46–49.
68. Id . at 49 (“The pharmacist must be certain to clean the balances and pans daily and keep all weights,
measures, and vessels clean.  The shop was to be kept well stocked and the display attractive; the inventory
was to be watched carefully, and the deteriorated materials were to be replaced.  Finally, the pharmacist
was admonished to keep his profits moderate.”).
69. Id. at 55–56.
70. Id. at 56.
71. Higby, supra note 36, at ix; Gregory J. Higby, American Pharmacy’s First Great Transformation:
Practice, 1852–1902, in AMERICAN PHARMACY: A COLLECTION OF HISTORICAL ESSAYS 1 (Gregory J.
Higby & Elaine C. Stroud eds. 2005).
72. Higby, supra note 36, at ix; see HUISKING, supra note 65.
73. Higby, American Pharmacy’s First Great Transformation: Practice, 1852–1902, supra note 71, at 1.
74. Id.; see also SONNEDECKER, supra note 37, at 308–09 (discussing the soda fountain as an institution of
the neighborhood pharmacy).
75. Higby, American Pharmacy’s First Great Transformation: Practice, 1852–1902, supra note 71, at 1.
76. Id.
77. Id . at 1–2; see also SONNEDECKER, supra note 37, at 310–11 (discussing the variety of items sold).
102
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In the early 1900s, pharmacy practice was considered “full-time employ-
ment, but only a part-time practice of pharmacy.”78  The practice was attractive
to American youth who liked the idea of owning a business while also practicing
a profession.79  By the mid-century, “[a]t least half of all pharmacists were own-
ers or managers of the establishment in which they worked in a triple role as
proprietor, professional pharmacist, and general salesperson.”80  With the addi-
tion of soda fountains and general store items, drugstores became the social meet-
ing place in both large and small communities alike.81
Around the same time, small and privately owned drugstores were being
slowly replaced by large drugstore chains.82  These smaller drugstores found it
difficult to compete with the economic efficiencies of large pharmacy chains like
Walgreens, and the increased competition from sales of non-medical goods by su-
permarkets and department stores.83 Large chains had the economic means to
aggressively mass merchandise and commercialize retail pharmacy at a level
with which small privately-owned pharmacies could not compete.84
Today both private and corporate pharmacies continue to sell merchandise
other than medicine.  They have diversified their practices by also serving the
general needs of clients by stocking food items, household goods, cosmetics, and
recreational goods.85  Nevertheless, pharmacies continue to play a crucial role in
providing for the medical needs of their customers.
C. Traditional Regulation of Pharmacy
Pharmacy, for the most part, is a self-regulated profession.86  At the begin-
ning of the twentieth century, pharmacists chose to organize themselves in state-
level systems to help regulate the emerging profession.87  With the help of lawyer
and pharmacist James Hartely Beal, and other pharmacy leaders, people within
the industry influenced the development of national organizations to oversee the
licensing, practice, and state regulation of pharmacy.88  For example, ever since it
was founded in 1852, the American Pharmacist Association (“APhA”) has been
influential in regulating the education of pharmacists and adopting uniform
78. Glenn Sonnedecker, The American Practice of Pharmacy, 1902–1952, in AMERICAN PHARMACY: A
COLLECTION OF HISTORICAL ESSAYS 5 (Gregory J. Higby & Elaine C. Stroud eds. 2005).
79. Id.
80. Id . at 6.
81. COWEN & HELFAND, supra note 1, at 188.
82. Sonnedecker, supra note 78, at 6–7. See generally SONNEDECKER, supra note 37, at 297–300.
83. Sonnedecker, supra note 78, at 6–7.
84. Id .
85. See generally COWEN & HELFAND, supra note 1, at 188.
86. ABOOD, supra note 14, at 275.
87. See id. at 275–76.
88. See id. at 276.
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practices and standards.89  Additionally, the National Association of Boards of
Pharmacy (“NABP”)90 provided a national forum that facilitated communication
between state representatives and pharmacists to help develop professional poli-
cies, standards, and model legislation to better regulate the industry.91  It also
developed the national licensure exam that each state administers to pharmacy
candidates.92
While the APhA and NABP are, for the most part, voluntary organizations,
state legislatures have the power to regulate the practice of pharmacy by law.93
This power is derived from the states’ police powers and the Tenth Amend-
ment.94  Most state regulation begins with the passage of state pharmacy practice
acts or other regulatory schemes that establish each state’s board of pharmacy.95
As an administrative agency, the purpose of the state board of pharmacy is to
“protect the public health, safety, and welfare.”96  Although the state board of
pharmacy is usually comprised of practicing pharmacists, consumers, and other
healthcare professionals,97 the board is not meant to protect the profession of
pharmacy but rather to protect the public.98  In addition to issuing licenses to
practitioners, the state board also oversees the licensure of pharmacies99 and disci-
plinary actions against pharmacists and pharmacies.100
In New York, for example, the state legislature created the State Education
Department and the Board of Regents to jointly oversee all of the public health
professions in the state.101  The Board of Regents prescribes the rules and regula-
tions for all health professionals in New York.102  This agency created the State
Board of Pharmacy, which ensures that pharmacists adhere to the rules of profes-
sional conduct.103  Under Title VIII, Article 137, Section 6804 of the Education
Law, the New York State Board of Pharmacy has the power to (1) regulate the
89. Higby, supra note 36, at xi.
90. The NABP was founded in 1904. SONNEDECKER, supra note 37, at 218.
91. ABOOD, supra note 14, at 278.
92. PISANO, supra note 3, at 5.
93. SONNEDECKER, supra note 37, at 214.
94. ABOOD, supra note 14, at 275.
95. SONNEDECKER, supra note 37, at 214.
96. ABOOD, supra note 14, at 278.
97. See id. These positions are politically appointed directly by the governor. Id.
98. Id.
99. Id. at 280 (“The state board will issue a license to operate a pharmacy only to those that meet established
standards relating to structural matters (e.g., equipment), library, and assurance of  pharmacist
supervision.”).
100. Id. at 281.
101. See  N.Y. COMP. CODES R. & REGS. tit. 8 §§ 3, 17.5 (2005).
102. See id. § 17.5.
103. See id.; see also N.Y. EDUC. LAW § 6804 (2005).
104
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practice of pharmacy, (2) investigate alleged violations of the provisions of this
article, and (3) conduct hearings and prescribe penalties when pharmacists are in
violation of policies.  The members of the State Board of Pharmacy are appointed
by the Board of Regents on the recommendation of the New York State
commissioner.104
The federal government also regulates certain aspects of pharmaceutical
practice, deriving its power from its interstate commerce powers.105  This in-
cludes the enactment of practice-oriented drug laws that directly affect the dis-
pensing of medicine.106  These laws were enacted primarily to protect the public
from the potential risks of abusing dangerous products.107 The major practice-
oriented drug law enacted in the United States is the Federal Controlled Sub-
stances Act of 1970 (“CSA”).108  In addition to regulating the manufacture and
distribution of controlled substances,109 the CSA regulates the dispensing of con-
trolled substances by pharmacists because controlled substances have a high poten-
tial to be abused by patients.110  The Drug Enforcement Administration (“DEA”)
is the administrative agency in charge of controlling access to this class of
medicines.111  Among other regulations, the DEA placed prescription-dispensing
limitations on these types of drugs.112  States are otherwise free to regulate the
dispensing of controlled substances as long as the state regulation is stricter than
the federal regulation.113
D. A Pharmacist’s Discretion to Fill Prescriptions
In general, “[a] druggist (sic) is not obligated to fill any and all prescriptions,
but may refuse to fill one for good reason . . . .”114  In practice, laws governing a
pharmacist’s discretion to refuse to fill a prescription because it would violate his
or her personal beliefs vary greatly from state to state.115  Some states, including
104. See N.Y. EDUC. LAW § 6804.
105. ABOOD, supra note 14, at 20; see also SONNEDECKER, supra note 37, at 219–20.
106. PISANO, supra note 3, at 29.
107. ABOOD, supra note 14, at 2–3.
108. PISANO, supra note 3, at 29.
109. Controlled substances are drugs that “are subject to, or have the potential for, abuse or physical or psycho-
logical dependence.” Id.  Some examples include Percocet, Demerol, and Codeine.  Id. at 42.
110. Id. at 29.
111. Id.
112. Id.
113. Id. at 30.  For example, Massachusetts further regulates the dispensing of Schedule II controlled sub-
stances by mandating that the prescription be filled within five days after the date on which it was issued
and limits the supply to a thirty-day supply per prescription only. Id .
114. STEVEN STRAUSS, THE PHARMACIST AND THE LAW 28 (1980) (citing 28 C.J.S., Supp., Drugs & Narcot-
ics, § 43).
115. Feder, supra note 16, at 2.
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Georgia, Arkansas, South Dakota, and Mississippi, recognize pharmacists’ rights
to refuse to fill a prescription and place no affirmative duty on them to accommo-
date the consumer.116  By contrast, the State of Illinois has chosen to require the
timely filling of any valid prescription—no matter what the circumstance.117
States such as North Carolina, Wisconsin, Texas, and Nevada have chosen a
middle-of-the-road approach, allowing pharmacists to refuse to fill a prescrip-
tion, but placing on them (or on their employer) a duty to have procedures in
place to ensure that the patient can still get his medication filled at another phar-
macy or by another pharmacist in the same pharmacy.118  And finally, some
states, such as New York, remain silent on the issue.
In addition, drug product selection laws may also affect a pharmacist’s dis-
cretion in certain narrow circumstances.119  The Food and Drug Administration
(“FDA”) oversees and keeps a list of suitable substitutions and equivalent generic
drugs and allows pharmacists some latitude to dispense a different product with-
out the doctor’s consent.120  In some situations, the pharmacist has the discretion
to substitute the drug for its bioequivalent,121 and in others, the states have the
option of allowing pharmacists the discretion to use it as an appropriate
substitution.122
A pharmacist’s discretion to fill a prescription came to the forefront of politi-
cal debate when the governor of Illinois, Rod Blagojevich, issued an executive
order compelling all pharmacies to dispense the “morning after” birth control pill,
even if the pharmacist objects to dispensing the medication on moral or religious
grounds.123  Within a month, six pharmacists refused to fill several prescriptions
despite the governor’s order.124
116. Id . at 4.
117. Id . at 3 & n.6 (citations omitted).
118. Id . at 3–4; see also id. at 3 n.11 (“For example, Texas law provides that a pharmacist ‘may not refuse to
transfer original prescription information to another pharmacist,’ and Oklahoma law specifies that ‘[n]o
legally-competent practitioner of the healing arts shall refuse to honor the requests of his patient to have
his prescription transferred to the registered pharmacist or pharmacy of the patient’s choice.’ ”) (citations
omitted).
119. See generally PISANO, supra note 3, at 33–34.
120. Id . at 34.
121. Id .
122. Id .  This is because B rated drugs may not be bioequivalent, just merely therapeutically equivalent.
123. See  Molly McDonough, Rx For Controversy, 4 ABA J. EREPORT 23 (2005); Feder, supra note 16, at 3;
Melissa Duvall, Comment, Pharmacy Conscience Clause Statutes: Constitutional Religious “Ac-
commodations” or Unconstitutional “Substantial Burdens” on Women? 55 AM U. L. REV. 1485,
1488 n.12 (2006); Claire A. Smearman,  Drawing the Line: The Legal, Ethical and Public Policy
Implications of Refusal Clauses for Pharmacists, 48 ARIZ. L. REV. 469, 470–471 (2006).
124. See McDonough, supra note 123; Smearman, supra note 123, at 470–71; Kari Lydersen, Pharmacies
Required to Fill Prescriptions for Birth Control, WASH. POST, Apr. 2, 2005, at A02; Dailard, supra
note 16.
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III. THE ACCESS TO LEGAL PHARMACEUTICALS ACT
In the wake of the controversy over the “morning after” pill, proponents of
patients’ rights proposed federal “duty to fill” legislation that would ensure the
availability of legally prescribed medicines to all patients.125  Proponents support
the enactment of nationwide legislation to govern pharmacist conduct, reasoning
that a patient has a right to acquire, without delay and no matter where he lives,
all legally valid medicines prescribed by his doctor.126  The major proposal being
considered is called the Access to Legal Pharmaceuticals Act (“ALPhA”), which
was introduced to the House of Representatives on April 14, 2005 by Represen-
tative Carolyn B. Maloney.127  This legislation would prevent pharmacies from
denying the sale of legal, physician-prescribed medicines because of a pharmacist’s
religious beliefs.128
This note contends that the language of the bill is far too broad.  It could
have the effect of taking away important pharmacist discretion when it comes to
filling prescriptions and would allow patients to dictate the types of medication
pharmacies order. Additionally, the strict conditions and harsh penalties pre-
scribed by this act would disproportionately hurt small neighborhood pharmacies
over large corporate ones.  Finally, the act requires pharmacists to go above and
beyond an ordinary duty of care.  Because there are many states that have re-
mained silent on this issue, federal legislation should be enacted, but with much
125. Statement of Linda Garrelts MacLean, RPh, CDE, supra note 6 (discussing the negative impact that the
proposed duty to fill legislation would have on pharmacists); see also Feder, supra note 16 (summarizing
state duty to fill laws).
126. Feder, supra note 16, at 2.
One bill, H.R. 1539 would require pharmacies to ensure that, if a pharmacist refused to fill
a prescription on the basis of religious beliefs or moral convictions, then the prescription
would be filled by another pharmacist employed by the pharmacy with in four hours of such
refusal.  Likewise, companion bills H.R. 1652 and S. 809 would require pharmacies to
ensure that prescriptions are filled without delay by another of their pharmacists if one
pharmacist refuses and would also prohibit pharmacies from employing any pharmacist
who acts with intent to prevent or deter a customer from filling a valid prescription.  In
addition, S. 778 would require pharmacies that receive Medicare or Medicaid payments to
ensure that valid prescriptions are filled without unnecessary delay or interference.
Id.
127. Press Release, Rep. Carolyn Maloney, Lawmakers Introduce Legislation to Ensure Pharmacies Fill All
Dr. Prescriptions (Apr. 14, 2004), available at http://maloney.house.gov/index.php?option=content&task
=view&id=113&Itemid=61.
128. Id. In justifying the bill, Congressmen Christopher Shays insisted that “[p]harmacists are health profes-
sionals whom we trust to fulfill their professional responsibilities to their patients . . . .  It is unacceptable
for a pharmacist to withhold any safe, legal medication and it is time to put an end to this abuse of trust.”
Id. Judy Waxman, VP of Health and Reproductive Rights at the National Women’s Law Center agreed,
stating that “[t]his bill would ensure that every woman can walk into her local pharmacy with a valid
prescription and leave with her medication in hand and her dignity in tact [sic].” Id.; see also Duvall,
supra note 123, at 1494–95; Smearman, supra note 123, at 539; Minh N. Nguyen, Comment, Refusal
Clauses & Pro-Life Pharmacists: How can we protect ourselves from them?, 8 SCHOLAR 251,
272–73 (2006).
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narrower language to ensure that a pharmacist’s professional and business discre-
tion is preserved.  Any legislation must also avoid placing affirmative duties on
pharmacists, such as forced ordering of medication, forced filling of prescriptions,
or forced hiring of extra pharmacists.
A. The broad language of ALPhA may force pharmacists to fill
legally valid medications despite harm to the consumer
The purpose of ALPhA is “to establish certain duties for pharmacies when
pharmacists employed by the pharmacies refuse to fill valid prescriptions for
drugs or devices on the basis of personal beliefs, and for other purposes.”129  Le-
gally valid prescriptions however, are not the same as therapeutically safe pre-
scriptions,130 and the language of this bill takes away the pharmacist’s discretion
in assessing whether medication is appropriate or safe.131
There are many legitimate reasons why a pharmacist might exercise his or
her discretion not to fill a prescription, only one of which includes an objection
based on personal belief.  Pharmacists are experts on drug interactions, appropri-
ate drug therapies, and patient care, especially in the realm of new or experimen-
tal drugs.132  They gain that expertise through six years of study, clinical
experience, and continuing education.133  Based on this training and expertise, it
is not surprising that a pharmacist’s opinion on appropriate drug therapy may
differ from that of the doctor.  Under ALPhA, when a “morally objectionable”
drug such as Plan B134 is legally prescribed by a doctor, but there are questions
about whether the patient could be hurt by the therapy, a pharmacist who exer-
cises his or her expert opinion in refusing to fill that prescription may still be
susceptible to penalties.  This is because the language of the bill fails to differenti-
ate between therapeutically safe and legally valid prescriptions.135  This bill irre-
129. H.R. 1652, 109th Cong. (2005).
130. Statement of Linda Garrelts MacLean, RPh, CDE, supra note 6.
Duty to full legislation would require pharmacies or pharmacists to dispense legal prescrip-
tions.  When poorly crafted, such a requirement conflicts with the pharmacist’s legal respon-
sibility to assess the clinical safety and appropriateness of the prescription . . . . A
prescription calling for a 10 fold overdose is lawful, but likely fatal to the patient . . . . A
prescription calling for an oral contraceptive for a patient with a history of thromboembolic
disease is lawful, but may result in patient harm.
Id. at 6.
131. Smearman, supra note 123, at 539.
132. See supra notes 59–64 and accompanying text.
133. Id.
134. The FDA has recently approved making Plan B, the “morning after” pill, available over the counter for
women over the age of eighteen.  Women under the age of eighteen still need a prescription. See  Press
Release, U.S. Food and Drug Admin., FDA Approves Over-the-Counter Access for Plan B for Women 18
and Older Prescription Remains Required for Those 17 and Under (Aug. 24, 2006), available at http://
www.fda.gov/bbs/topics/NEWS/2006/NEW01436.html.
135. H.R. 1652, 109th Cong. (2005).
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sponsibly places an affirmative duty on pharmacists to fill legally prescribed
medications,136 despite possible harmful side effects that may result.137  In addi-
tion, fear of penalties would greatly interfere with the pharmacist’s clinical judg-
ment and would work to decrease the quality of patient care.138
B. The broad language of ALPhA subjects pharmacy policy and
practice to patients consent
Section 249(a)(1) of the ALPhA governs pharmacy policy as to who must fill
morally objectionable prescriptions when the medication is already in stock in the
pharmacy.139  It reads:
[T]he pharmacy ensures, subject to the consent of the individual
presenting the prescription . . . that the prescription is . . . filled by
another pharmacist employed by the pharmacy.140
This language places an affirmative duty on the pharmacy to ensure that, at all
times, there is a pharmacist available to fill prescriptions that another pharmacist
refuses to fill because of a moral objection.  It also takes away the option of trans-
ferring the prescription to another pharmacy, a normal and valid pharmacy
practice, unless the patient consents.141  Without affording pharmacists the option
of exercising the normal pharmacy practice of transferring prescriptions, phar-
macy practice becomes subject to patient approval.  The prohibition of transfer-
ring a prescription to another pharmacy is particularly troublesome.  If a
situation arose where another pharmacist could not be reached, the pharmacy
would be subject to a fine if it refused to fill the prescription.  Small pharmacies
would be far more susceptible to these penalties because they lack the personnel
and resources to which the larger chain drugstores have access.142
The language of ALPhA would also force pharmacies to order medications
that they might not ordinarily carry.143  Section 249(a)(2) governs the ordering of
medicine not normally carried by the pharmacy.  It reads:
136. Id.
137. For example, although Plan B is an FDA approved drug, there are numerous side effects, drug-to-drug
interactions, and long term use consequences that have not been officially assessed.  Plan B additionally
may not be safe for diabetic women to take because of the possible effects it may have on blood-glucose
levels. See  Prescribing information of Plan B provided by its provider, Duramed, available at http://
www.go2planb.com/PDF/PlanBPI.pdf.
138. See  Part III.B.
139. See H.R. 1652, 109th Cong. § 249(a)(1) (2005).
140. Id. § 249(a)(2)(B) (emphasis added).
141. See  Statement of Linda Garrelts MacLean, RPh, CDE, supra note 6 (stating that transferring prescrip-
tions is a type of system that ensures patients receive access to care).
142. See  Sonnedecker, supra note 78, at 299 (describing the earning and resource differences of individual and
chain drugstores). See generally Statement of Linda Garrelts MacLean, RPh, CDE, supra note 6.
143. See  H.R. 1652, 109th Cong. § 249(a)(2); Press Release Rep. Carolyn Maloney, supra note 127.
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The pharmacy ensures, subject to the consent of the individual,
that the product is, without delay, ordered by another pharmacist em-
ployed by the pharmacy.144
While the Act does not expressly require that all types of birth control must be on
hand at the pharmacy at all times, it does require that the pharmacy order that
medication whenever a patron requests it.145
In looking at the language of the statute, the ALPhA goes farther than reg-
ulating pharmacist conduct by affecting the business decisions of pharmacies with
respect to ordering medications. The ALPhA “dictat[es] how a business must ac-
commodate its [patients].”146
[D]epending on the patient’s needs, how quickly the pharmacy can re-
ceive the drug, and how much more the drug may cost the pharmacy
(special orders may cost the pharmacy more—and the pharmacy may
not receive any payment to cover those additional costs), special-order-
ing the drug may not be a viable option.147
On the business end of the profession, duty to fill legislation has the effect of:
[Compelling] health care providers and businesses to provide certain
services.  Decisions about what services to provide and by whom should
be left up to individual health care providers.  Decisions about which
systems to implement and how to implement them should be left up to
the pharmacy managers and pharmacists.  Patients will choose the
pharmacy and pharmacists who best serve their needs, and market
forces will dictate what services the pharmacies provide.148
Subject to a patient’s consent, and without allowing the pharmacy the option of
transferring the prescription, pharmacists would be compelled to order medica-
tions at the patient’s demand.  Medicines that patients use on a weekly or
monthly basis would have to be ordered in advance and on a regular basis by the
pharmacy, despite how the pharmacist may want to run his own business.149
Pharmacy as a business enjoys the same freedom of contract as other businesses do;
the owner has the right to decide what he or she wants to sell.  This is no differ-
ent whether the owner of the pharmacy is a licensed pharmacist or a lay person.
The bill’s language improperly infringes on this freedom of contract.
144. H.R. 1652 § 249(a)(2) (emphasis added).
145. See id.; Press Release Rep. Carolyn Maloney, supra note 127.
146. See generally Press Release Rep. Carolyn Maloney, supra note 127.
147. Statement of Linda Garrelts MacLean, RPh, CDE, supra note 6.
148. Id .
149. Id.
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C. The requirements and penalties established in the ALPhA are
unduly harsh to small, independent pharmacies
Section 249(c) describes the civil and private penalties to which pharmacies
will be subject for failing to follow the conditions set by the ALPhA.150  These
include “a civil penalty in an amount not exceeding $5,000 per day of violation,
not to exceed $500,000 for all violations adjudicated in a single proceeding,”151
and a cause of action for any person injured as a result of a violation including,
“actual and punitive damages, injunctive relief, and a reasonable attorney’s fee
and cost.”152
Small neighborhood pharmacies would bare the brunt of the ALPhA penal-
ties.153  As stated above, this legislation puts an affirmative duty on the phar-
macy to guarantee that a pharmacist at that particular pharmacy will always be
on hand to fill prescriptions that other pharmacists may have an objection to
filling.154  It also puts a strict timing duty on the pharmacy to fill such prescrip-
tions.155  The prescription must be filled without delay, which is defined in the
act as “the amount of time it would take the pharmacy to fill a prescription that is
not personally objectionable to the pharmacist.”156  If the pharmacy usually takes
one hour to fill a prescription, then that is the time frame to which the pharmacy
must adhere in filling morally objectionable prescriptions.157  In addition, placing
special orders for medications costs more money—money that small pharmacies
cannot afford to lose when competing with large corporate chains.158  Small
pharmacies simply do not have the same resources as large corporate pharmacies
to adhere to the strict timing and ordering requirements of this act.159  By re-
150. See  H.R. 1652, 109th Cong., § 249(c).
151. Id.
152. Id.
153. Statement of Linda Garrelts MacLean, RPh, CDE, supra note 6; Dailard, supra note 16.
154. H.R. 1652 § 249(a)(1).
If a product is in stock and a pharmacist employed by the pharmacy refuses on the basis of a
personal belief to fill a valid prescription for the product, the pharmacy ensures, subject to
the consent of the individual presenting the prescription in any case in which the individual
has reason to know of the refusal, that the prescription is, without delay, filled by another
pharmacist employed by the pharmacy.
Id.; see also Press Release Rep. Carolyn Maloney, supra note 127.
155. Press Release Rep. Carolyn Maloney, supra note 127.
156. H.R. 1652, 109th Cong., § 249(d)(8) (“The term ‘without delay,’ with respect to a pharmacy filling a
prescription for a product or ordering the product, means within the usual and customary timeframe at the
pharmacy for filling prescriptions for products for the health condition involved or for ordering such
products, respectively.”); see also Press Release Rep. Carolyn Maloney, supra note 127.
157. Press Release Rep. Carolyn Maloney, supra note 127.
158. Statement of Linda Garrelts MacLean, RPh, CDE, supra note 6; see also Dailard, supra note 16, at
11–12.
159. See  Statement of Linda Garrelts MacLean, RPh, CDE, supra note 6; Nguyen, supra note 128, at
272–73.
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moving the option of transferring the prescription to another area pharmacy, the
small neighborhood pharmacy is particularly susceptible to fines under this act.160
D. The ALPhA requires pharmacists to provide patients more than
ordinary care
The act as a whole also requires pharmacists to carry out a set of actions that
go above and beyond ordinary patient care.  Traditionally, a pharmacist only
owes a duty of ordinary care that reflects the “degree of knowledge, skill, and
diligence exercised by other members of the profession” to their patients.161  New
York requires that pharmacists meet this duty of ordinary care.162
In France v. State of New York, for example, a prison pharmacist failed to
fill an inmate’s prescription for an ointment to soothe a skin condition called
atopic dermatitis for a full month.163  As a result, the prisoner “suffered discom-
fort during this period, as his skin dried, cracked and scaled and he was unable to
relieve any of his pain without the ointment.”164  Because the state failed to pro-
vide “any evidence explaining why the druggist refused to fill the prescrip-
tion,”165 the pharmacist’s failure to fill the prescription was a breach of ordinary
care which rendered him liable for the patient’s damages.166
Ordinary care in reference to pharmacy practice was evaluated in this case
as “the highest practicable degree of thoughtfulness and vigilance, and the most
exact and reliable safeguards consistent with the reasonable conduct of the busi-
ness.”167  Ordinary care, therefore, is a rule of reason and only mandates that a
pharmacist do what is reasonable under the circumstances in dealing with
patrons.
In McChonchie v. Wal-Mart Stores, Inc., the court held that refusing to
fill an unprofitable prescription was neither a breach of ordinary care nor unpro-
160. Dailard, supra note 16.
161. Steven W. Huang, The Omnibus Reconciliation Act of 1990: Redefining Pharmacists’ Legal Re-
sponsibilities, 24 AM. J. L. & MED. 417, 421 (1998) (quoting David J. Marchitelli, Annotation, Liabil-
ity of Pharmacist who Accurately Fills Prescription for Harm Resulting to User, 44 A.L.R. 393
(1996)); see also Selected Recent Court Decisions: Pharmacy: Negligence in Filling Prescriptions—
Hooks SuperX, Inc. v. McLaughlin, 20 AM. J. L. & MED. 503, 508 (1994) (discussing legal standard of
care for pharmacists).
162. Willson v. Faxon, 208 N.Y. 108, 114 (1913) (“The negligence which must be established to render a
druggist liable, in [a case based upon the sale of a poison to a person who called for a harmless drug], is
measured by his duty; and while this is only to exercise ordinary care, the phrase ordinary care in reference
to the business of a druggist must be held to signify the highest practicable degree of prudence, thoughtful-
ness and vigilance, and the most exact and reliable safeguards consistent with the reasonable conduct of the
business.”).
163. 506 N.Y.S.2d 254, 254–55 (1986).
164. Id. at 255.
165. Id.
166. Id.
167. Willson , 208 N.Y. at 114.
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fessional conduct.168 McChonchie involved a pharmacist who was fired for fill-
ing a prescription that his employer told him not to fill.169  The major issue in the
case was “whether, under New York law, an employer’s termination of a licensed
pharmacist for disobeying a directive that the pharmacist believed to be unethical
and illegal is actionable as a breach of contract based upon an implied-in-law
obligation.”170  The plaintiff pharmacist’s employer noticed that profit margins
had been falling as a result of filling bulk prescriptions for a veterinarian, Dr.
Prendergast.171  He therefore ordered the pharmacist to no longer fill any pre-
scription written by Dr. Prendergast.172  The plaintiff informed his employer
that he believed it would be “against the law and pharmaceutical ethics to refuse
to fill or refill a prescription based on profit margin.”173  His employer disagreed
and insisted that the pharmacist not fill the prescriptions.174  The pharmacist
disobeyed his employer’s mandate and filled three more prescriptions for Dr.
Prendergast.175  As a result, the plaintiff pharmacist was fired.176
The court ruled for the defendant and held that “[p]laintiff can point to no
rule specifically covering the conduct in question, i.e., refusing to fill large volume
prescriptions because of economic or licensing considerations.”177  The court rea-
soned that “[n]one of the statements in defendant’s own internal policy upon
which plaintiff relies, such as those requiring that Wal-Mart pharmacists are to
‘maintain high ethical standards’ and ‘perform the legal and moral responsibility
to the profession and to the general public,’ render [the employer’s] mandate im-
proper.”178  The court found that in the absence of evidence showing that the
pharmacist reasonably believed that the employer’s mandate was a violation of
the Rules of the Board of Regents Section 29.2,179 refusing to fill a prescription
for a regular customer for economic reasons was not a violation of the ethics rules
or a pharmacist’s duty of care.180
168. 985 F. Supp. 273, 279 (N.D.N.Y. 1997).
169. Id. at 276.
170. Id . at 274.
171. Id. at 275.
172. Id.
173. Id.
174. Id.
175. Id.
176. Id. at 275–76.
177. Id. at 279.
178. Id.
179. Section 29.2(a) states that “unprofessional conduct shall include: (1) abandoning or neglecting a patient or
client under and in need of immediate professional care, without making reasonable arrangements for the
continuation of such care . . . .” N.Y. COMP. CODES R. & REGS. tit. 8 § 29.2(a) (2006).
180. McConchie , 985 F. Supp. at 280.  The court also said that Prendergast was “able to fill the prescriptions
at another pharmacy in the area” and that “Prendergast never told [the pharmacist] that the prescriptions
were for medical emergencies.” Id .
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Under the ALPhA, pharmacists would presumably be held strictly liable for
damages flowing from the failure to fill birth control and emergency contracep-
tives.  This is because the act places an affirmative duty to fill all legally valid
medications despite harm to the consumer.181  However, courts have traditionally
been reluctant to hold pharmacists to a standard of strict liability.182  Although
there is a duty to dispense medications properly,183 there has been no correspond-
ing duty to fill every prescription handed to a pharmacist.
IV. THE FEDERAL GOVERNMENT SHOULD REVISE THE ALPhA BASED ON THE NEW
YORK STATE BOARD OF PHARMACY’S GUIDELINE
Laws that govern pharmacist conduct should recognize the importance of
patients receiving legally prescribed medications, but must also preserve pharma-
cists’ discretion.184  Preserving pharmacist discretion is not an unusual considera-
tion because many other federal and state regulations do just that.185  While the
ALPhA limits a pharmacist’s discretion, other federal and state regulations such
as the CSA and drug product selection laws are narrowly tailored to recognize
that a pharmacist’s expertise in clinical practice and the business of pharmacy are
valuable and necessary safeguards of our healthcare system.186  The ALPhA
should be rewritten with these other regulations in mind.  In particular, the fed-
eral government could look to language similar to that contained in the New
York State Board of Pharmacy’s Policy Guideline Concerning Matters of
Conscience,  to guide it in constructing a narrowly tailored regulation that
achieves its goals without unduly burdening the business and practice of phar-
macy.187  The language of this policy balances the interests of pharmacists and
patients by preserving pharmacist discretion, protecting the business of phar-
macy, better protecting small neighborhood pharmacies, and better following
other pharmacy practice acts that affect pharmacist discretion, while still respect-
ing a patient’s right to obtain legally prescribed medication.  Additionally, it is
important for the federal government to look toward state recommendations for
guidance because states have more experience regulating pharmacy practice.
181. See supra Part II.A.
182. Huang, supra note 161, at 421–22.
183. Id. at 428.
184. See generally Statement of Linda Garrelts MacLean, RPh, CDE, supra note 6; Dailard, supra note 16,
at 10 (discussing the APhA’s adopting a policy that both “recognizes the individual pharmacist’s right to
exercise conscientious refusal and supports the establishment of systems to ensure patient access to legally
prescribed therapy without compromising the pharmacist’s right of conscientious refusal”).
185. See supra Part III.A.
186. See supra notes 108–20 and accompanying text.
187. Memorandum from Lawrence H. Mokhiber, Executive Secretary, New York State Education Depart-
ment, to Supervising Pharmacists (Nov. 18, 2005), available at http://www.op.nysed.gov/pharm
conscienceguideline.htm.
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A. Federal and state statutes that regulate pharmacy are usually
tailored to protect the public while keeping pharmacist
discretion intact
Preserving pharmacist discretion in the regulation of pharmacy practice is
an important consideration in tailoring both federal and state regulations.  As
stated above, the CSA regulates the dispensing of controlled substances by phar-
macists because controlled substances have a high potential to be abused by pa-
tients.188  The DEA placed prescription-dispensing limitations on these drugs by
placing them in different categories, reflecting their addictiveness and danger to
patients’ health.189  Depending on the category or schedule in which the drug is
placed, the pharmacist does not have discretion to refill the prescription under
certain circumstances.190  For example, drugs that fall under Schedule II status
such as Morphine, Percodan, Amphetamines, and Barbiturates cannot be refilled
without a prescription, and if a partial quantity is dispensed, the remainder must
be given to the patient within seventy-two hours.191  However, the pharmacist
retains discretion to “dispense partial quantities of Schedule II medications to
patients in long-term care facilities or who are terminally ill for up to sixty days
from the original date of the prescription’s issuance.”192  Schedule II drugs also
cannot be filled by a verbal prescription.193  However, again, in an emergency
situation, the CSA allows the pharmacist the discretion to dispense medications
but only what is necessary to get the patient through the emergency and only
upon oral notification by the prescribing physician.194  Additionally, pharmacists
retain discretion not to fill controlled substance prescriptions when they believe
that the prescription was not dispensed in good faith or for a legitimate medical
purpose.195
Another type of regulation that preserves pharmacists’ discretion is drug
product selection laws.196  These regulations involve a combination of federal and
state laws.197  These laws recognize that when a doctor writes a prescription for
a drug, situations may arise where dispensing a different product that is either
the bioequivalent or therapeutic equivalent to the prescribed medication is better
188. PISANO, supra note 3, at 29.
189. Id. at 30.
190. Id . at 30–33.
191. Id . at 31.
192. Id .
193. Id . at 32.
194. Id .
195. Id . at 39.
196. See generally id. at 33–34.
197. Id .
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or more economically feasible to the client.198  The federal government, through
the FDA, publishes a list of suitable substitution products called “Approved Drug
Products with Therapeutic Equivalence Evaluations.”199  These evaluations are
prepared as a guide for healthcare professionals to evaluate feasible substitutes to
a physician’s recommendation.200  If the FDA gives the drug an A rating, the
pharmacist has discretion to substitute the drug for its bioequivalent.201  If the
drug receives a B rating, states have the option of allowing pharmacists the dis-
cretion to use it as an appropriate substitution.202  Although these laws govern
pharmacists’ conduct, they do so in a narrowly tailored way to preserve pharma-
cists’ discretion.
B. The federal government should consider adopting similar
language to New York’s policy guideline
In response to pharmacists’ confusion as to what their obligations are to fill
prescriptions to which they may object, New York’s State Board of Pharmacy
issued a policy guideline.  The Policy Guideline Concerning Matters of Con-
science was adopted on November 18, 2005 and posted on the Office of the
Professions official website in March 2006.203  The pertinent language of the
recommendation reads as follows:
[I]f a pharmacy employs a pharmacist that has identified circumstances
that would preclude the filling of prescriptions for particular products,
the owner and supervising pharmacist should devise, within reason,
accommodations that will respect the pharmacist’s choice while assuring
delivery of services to patients in need.  This may include special atten-
tion to scheduling of professionals to allow a pharmacist who has a
religious, moral or ethical obligation to practice simultaneously with
another pharmacist who will fill the requested prescription, entering
into collaborative arrangements with pharmacies in close proximity, or
other accommodations designed to protect the public . . . .204
This recommendation does not have the force of law.  It does, however, help
ensure that patients get their medications without infringing upon a pharmacist’s
discretion.  The language also protects business decisions and allows pharmacies
the option to transfer a prescription or come up with other reasonable remedies
without the fear of harsh penalties typical of the duty to fill legislation.
198. Id . at 33.
199. Id. at 34.
200. Id .
201. Id.
202. Id .
203. Mokhiber, supra note 187.
204. Id.
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1. The language protects business decisions
The State Board of Pharmacy guideline provides:
When a pharmacist recognizes that his/her religious, moral, or ethical
belief, or any other factor, will result in the refusal to fill a prescription
that is otherwise available in a pharmacy the pharmacist has a pro-
fessional obligation to take appropriate steps to avoid the possibility of
abandoning or neglecting a patient.205
The otherwise available in a pharmacy language would appropriately protect
pharmacies that choose not to carry certain medications for any reason.  Unlike
duty to fill legislation, there is no affirmative duty placed on pharmacies to keep
in stock or to order certain medications.206  With the vast number of legal medi-
cations on the market today, it is an economic impossibility to carry them all and
pharmacies, as business entities, should be allowed to choose for any reason why
they would keep some medications in stock and not others.207  As such, pharmacies
will develop reputations for carrying or not carrying certain items, allowing con-
sumers to make an appropriate choice as to where they want to take their
business.208
In instances where the medication is carried by the pharmacy, but the phar-
macist on duty has an objection to filling it, the language also protects business by
allowing the pharmacy, and not the legislature, to prescribe the most beneficial
way to accommodate the patient in that local community.  The language states:
[T]he owner and supervising pharmacist should devise, within rea-
son , accommodations that will respect the pharmacist’s choice while as-
suring delivery of services to patients in need. This may include
special attention to scheduling of professionals to allow a pharmacist
who has a religious, moral or ethical objection to practice simultane-
ously with another pharmacist who will fill the requested prescription,
entering into collaborative arrangements with pharmacies in close
proximity, or other accommodations designed to protect the public
. . . .209
Unlike troublesome duty to fill legislation, the affirmative duty is on the phar-
macy to do what is reasonable.  Unlike with the ALPhA, transferring the pre-
scription is an option.  The language this may include expands the reasonable
205. Id . (emphasis added).
206. See supra notes 153–63 and accompanying text.
207. Statement of Linda Garrelts MacLean, RPh, CDE, supra note 6, at 7–8.
208. Id.  For example, Wal-Mart is known nationally for not carrying Plan B.  Holly Teliska, Note, Recent
Development: Obstacles to Access: How Pharmacist Refusal Clauses Undermine the Basic Health
Care Needs of Rural and Low-Income Women, 20 BERKELEY J. GENDER L. & JUST. 229, 240 n.88
(2005).
209. Mokhiber, supra note 187 (emphasis added).
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choice to possibilities not enumerated in the text.210  It recognizes that every com-
munity is different and gives the pharmacy a range of accommodations it may be
able to give to customers.  This language is also better in tune with the tradition
of holding pharmacists to an ordinary care standard and mimics the American
Pharmacist Association’s recommendations on the matter.211  The Association rec-
ommends that a pharmacist should never feel compelled to fill a prescription to
which he objects, but to make it known to the employer preemptively so that
measures can be reasonably devised to accommodate a patient in need of
medication.212
2. The language keeps pharmacists’ discretion and clinical duty
intact
The State Board of Pharmacy guideline provides:
Pharmacists have a professional responsibility to ensure that their pa-
tients obtain properly ordered and therapeutically appropriate medi-
cations in a timely manner with appropriate counseling from a
pharmacist . . . .  When a pharmacist recognizes that his/her religious,
moral, or ethical belief, or any other factor, will result in the refusal to
fill a prescription . . . the pharmacist has a professional obligation to
take appropriate steps to avoid the possibility of abandoning or
neglecting a patient . . . .213
This language helps protect both the patient and the pharmacist.  The “policy
balances the needs of the patient and the individual needs of the pharmacist, as
well as the pharmacist’s professional responsibility.”214  Instead of looking at
pharmacists as mere dispensers of medication, the language of the recommenda-
tion recognizes that pharmacists are independent thinking healthcare profession-
als, and does not mandate that all legally prescribed medications be filled in a
timely manner.  It recognizes that the issue to be resolved here is the filling of
prescriptions to which pharmacists may morally object, and uses narrow definite
language to achieve a resolution that could not be read to take pharmacists’ dis-
cretion away from filling prescriptions that they would otherwise deem as thera-
peutically dangerous.
210. Id.
211. See generally Statement of Linda Garrelts MacLean, RPh, CDE, supra note 6; Dailard, supra note 16
(discussing the APhA’s policy supporting “the individual pharmacist’s right to exercise conscientious refusal
and supports the establishment of systems to ensure patient access to legally prescribed therapy without
compromising the pharmacist’s right of conscientious refusal.”). See also Teliska, supra note 208, at 238
n.68.
212. Statement of Linda Garrelts MacLean, RPh, CDE, supra note 6, at 1; see also  Smearman, supra note
123, at 516.
213. Mokhiber, supra note 187 (emphasis added).
214. Statement of Linda Garrelts MacLean, RPh, CDE, supra note 6.
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V. CONCLUSION
The artisans of Mesopotamia and the alchemists of the Middle Ages could
never have foreseen how their independent practices could be so heavily regulated
and monitored in the distant future.  Even the druggists of the early nineteenth
and twentieth centuries may not have foreseen any reason why their practices
should be regulated.  In this day of mass-produced, publicly available drugs and
decreased need for handmade medicine, the professional world of the pharmacist
is vastly different than it was fifty years ago.  However, no matter the changes it
undergoes, the practice of pharmacy is still the practice of a profession, and any
laws prescribed to regulate that practice should recognize and respect pharmacists’
discretion as well as their business.  In contemplating legislation that will affect
pharmacy practice, the federal government should choose much narrower lan-
guage than that suggested by ALPhA to ensure a proper resolution to the problem
it wants to resolve.
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